TEMPO: Testing the Effect of Mindfulness for Prostatectomy Outcomes

Sponsor
University of Michigan Rogel Cancer Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT04727710
Collaborator
(none)
40
1
2
19.1
2.1

Study Details

Study Description

Brief Summary

This research project has 2 parts: The first part of the research is to develop a couples-based group mindfulness intervention for men undergoing prostatectomy, with input from patients and their partners. The second part is the trial registered here, which will pilot the researchers' mindfulness intervention, developed in part 1, and observe any reduction of distress for men undergoing prostatectomy and their partners.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mindfulness-based Intervention
  • Behavioral: Usual Care
N/A

Detailed Description

In part 1 of this research, researchers developed a couples-based group mindfulness intervention for men undergoing prostatectomy, with input from patients and their partners. Three patients who had previously undergone prostatectomy, and had expressed interest in participating in future research endeavors, and their partners were recruited to inform the design of the intervention. This group of six stakeholders identified the types of distress experienced by newly diagnosed prostate cancer patients and their partners, as well as their favored intervention approaches. These stakeholders do participate in the intervention or control groups in part 2 of this study.

Researchers used thematic analysis to assess the type of distress identified by stakeholders as well as approaches favored by them. They mapped these themes on the available mindfulness approaches, identified in their review, to develop an intervention that best captures the concerns of prostate cancer survivors and partners.

Part 2 is the pilot study. Researchers will enroll 20 more couples (men who are planning to undergo radical prostatectomy and their partners) to participate in a pilot study of the intervention. The pilot study will have 2 cohorts (groups). Half of the couples will be randomly assigned to the mindfulness intervention (intervention group) and the other half will receive the usual care (control group). All participants in the intervention and control groups in part 2 of the study will be analyzed to determine the effects and feasibility of the intervention.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Testing the Effect of Mindfulness for Prostatectomy Outcomes (TEMPO)
Anticipated Study Start Date :
Jul 1, 2022
Anticipated Primary Completion Date :
Feb 1, 2024
Anticipated Study Completion Date :
Feb 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Part 2: Couples-based mindfulness intervention

Mindfulness-based intervention + Usual care

Behavioral: Mindfulness-based Intervention
A self-directed, web-based mindfulness training. Investigators recommend one module a week for 6 weeks. Each module is approximately 1 hour long and consists of didactic components as well as meditation and mindfulness exercises.

Behavioral: Usual Care
Standard pre-operative survivorship seminar, offered monthly to all patients at Michigan Medicine about to undergo prostatectomy and their partners is aimed at promoting realistic expectations of prostatectomy outcomes, typical side effects, rehabilitation and emotional adjustment.

Active Comparator: Part 2: Usual care

Usual care

Behavioral: Usual Care
Standard pre-operative survivorship seminar, offered monthly to all patients at Michigan Medicine about to undergo prostatectomy and their partners is aimed at promoting realistic expectations of prostatectomy outcomes, typical side effects, rehabilitation and emotional adjustment.

Outcome Measures

Primary Outcome Measures

  1. Change in level of distress assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) Anxiety [Change from baseline at 3 and 6 months post-prostatectomy]

    This survey is administered as part of the patient's standard clinical care at University of Michigan. PROMIS SF Anxiety is an 8 item scale, each item is scored 1-5 where 1 is never and 5 is always. Higher scores indicate higher levels of anxiety.

  2. Change in level of distress assessed using the PROMIS SF Depression. [Change from baseline at 3 and 6 months post-prostatectomy]

    This survey is administered as part of the patient's standard clinical care at University of Michigan. PROMIS SF Depression is an 8 item scale, each item is scored 1-5 where 1 is never and 5 is always. Higher scores indicate higher levels of depression.

  3. Change in level of distress assessed using the PROMIS SF Positive Affect and Well Being [Change from baseline at 3 and 6 months post-prostatectomy]

    This survey is administered as part of the patient's standard clinical care at University of Michigan. PROMIS SF Positive Affect and Well Being is an 8 item scale, each item is scored 1-5 where 1 is never and 5 is always. Higher scores indicate higher levels of positive affect and well being.

Secondary Outcome Measures

  1. Change in salivary cortisol level (only patients will complete this, not partners) [Change from baseline at 3 months post-prostatectomy]

    Saliva is collected through an at home collection kit that is mailed to the lab.

  2. Change in level of distress assessed using the National Comprehensive Cancer Network (NCCN) Distress Thermometer [Change from baseline to 3 months post-prostatectomy]

    The NCCN Distress Thermometer is a 1-item global screener of distress using a 0-10 scale with 10 being most distressed.

  3. Change in level of distress assessed using the 5-facet Mindfulness Questionnaire (FFMQ) [Change from baseline at 3 months post-prostatectomy]

    FFMQ is a 15 item self-reported assessment of mindfulness. Each item is scored 1-5, with higher scores indicating higher use of 5 key facets of mindfulness: Observing; Describing; Acting with awareness; Non-judging; Non-reactivity.

  4. Change in urinary and sexual function assessed using Michigan Urological Surgery Improvement Collaborative (MUSIC) Expanded Prostate Cancer Index Composite (EPIC-26) [Change from baseline at 3 and 6 months post-prostatectomy]

    MUSIC's EPIC-26 is a 26-item survey. Response options form a Likert scale, and multi-item scale scores are transformed linearly to a 0-100 scale, with higher scores representing higher levels of continence and better erectile function.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Part 2--Pilot study:

Inclusion Criteria

  • Patients aged 35 - 90 who are planning to undergo radical prostatectomy at University of Michigan Hospital

  • Partners of these men, aged 18 and older

Exclusion Criteria:
  • Participants cannot be less than 18 years of age

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Rogel Cancer Center Ann Arbor Michigan United States 48109

Sponsors and Collaborators

  • University of Michigan Rogel Cancer Center

Investigators

  • Principal Investigator: Lindsey Herrel, MD, MS, University of Michigan

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Michigan Rogel Cancer Center
ClinicalTrials.gov Identifier:
NCT04727710
Other Study ID Numbers:
  • UMCC 2018.129
  • HUM00152158
First Posted:
Jan 27, 2021
Last Update Posted:
May 12, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Michigan Rogel Cancer Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 12, 2022